Skip to Content

Interferon Beta-1b

In the US, Interferon Beta-1b (interferon beta-1b systemic) is a member of the drug class interferons and is used to treat Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Colorectal Cancer and Multiple Sclerosis.

US matches:



CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Biological response modifier, BRM


Treatment of multiple sclerosis, MS

Foreign Names

  • Interferonum beta-1b (Latin)
  • Interferon beta-1b (German)
  • Intérferon bêta-1b (French)
  • Interferón beta-1b (Spanish)

Generic Names

Brand Names

  • Betaferon
    Bayer, Belgium; Bayer, Switzerland; Bayer, China; Bayer, Colombia; Bayer, Costa Rica; Bayer, Czech Republic; Bayer, Denmark; Bayer, Dominican Republic; Bayer, Ecuador; Bayer, Spain; Bayer, United Kingdom; Bayer, Greece; Bayer, Guatemala; Bayer, Hong Kong; Bayer, Honduras; Bayer, Croatia (Hrvatska); Bayer, Hungary; Bayer, Ireland; Bayer, Italy; Bayer, Lithuania; Bayer, Nicaragua; Bayer, Netherlands; Bayer, New Zealand; Bayer, Panama; Bayer, Philippines; Bayer, Portugal; Bayer, Sweden; Bayer, Slovakia; Bayer, El Salvador; Bayer, Turkey; Bayer Australia Ltd, Australia; Bayer Healthcare, Indonesia; Bayer Pharma, Austria; Bayer Pharma, Israel; Bayer Pharma AG, Norway; Bayer Santé, France; Bayer Schering, Bosnia & Herzegowina; Bayer Schering, Georgia; Bayer Schering, Serbia; Bayer Schering, Singapore; Bayer Schering, Tunisia; Bayer Schering, Taiwan; Bayer Schering, South Africa; Bayer Schering Pharma, Russian Federation; Bayer Thai Co Ltd, Thailand; Bayer Vital, Germany; Bayer Yakuhin, Japan; Bayer-Schering, Romania; Eurim-Pharm Arzneimittel GmbH, Austria; Haemato Pharm, Austria; Schering, Brazil; Schering, Chile; Schering, Iceland; Schering, Oman; Schering, Slovenia
  • Betaferone
    Bayer, Latvia
  • Betaseron
    Bayer, Canada; Bayer HealthCare, United States
  • Extavia
    Grupo Novartis, Spain; Novartis, Belgium; Novartis, Czech Republic; Novartis, Germany; Novartis, Denmark; Novartis, France; Novartis, United Kingdom; Novartis, Greece; Novartis, Hungary; Novartis, Ireland; Novartis, Lithuania; Novartis, Netherlands; Novartis, Norway; Novartis, Portugal; Novartis, Romania; Novartis, Sweden; Novartis Europharm, Slovenia; Novartis Europharm Limited, Latvia; Novartis Farma, Italy; Novartis Pharmaceuticals, Canada
  • Uribeta
    Probiomed, Dominican Republic; Probiomed, Guatemala; Probiomed, Honduras; Probiomed, Mexico; Probiomed, El Salvador

International Drug Name Search


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.